Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam D Post

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Clinical Epigenetics|November 29, 2019
Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinomaZachary L Watson, Tomomi M Yamamoto, Alexandra McMellen, et al.
American Journal of Obstetrics and Gynecology|February 29, 2024
Placental differences between severe fetal growth restriction and hypertensive disorders of pregnancy requiring early preterm delivery: morphometric analysis of the villous tree supported by artificial intelligenceAnna Jacobs, Saif I Al-Juboori, Evgenia Dobrinskikh, et al.
Oncogenesis|November 28, 2018
CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancerLindsay J Wheeler, Zachary L Watson, Lubna Qamar, et al.
Comparative Medicine|November 12, 2013
Assessing the pulsatility of luteinizing hormone in female vervet monkeys (Chlorocebus aethiops sabaeus)Sahar M Stephens, Francis K Y Pau, Tamer M Yalcinkaya, et al.
Breast Cancer Research and Treatment|December 19, 2012
Estrogen switches pure mucinous breast cancer to invasive lobular carcinoma with mucinous featuresPurevsuren Jambal, Melanie M Badtke, J Chuck Harrell, et al.
Gynecologic Oncology|May 25, 2025
The evolving role of HER2 in gynecologic oncology and clinical trial design: A gynecologic pathologist's perspectiveEseohi Ehimiaghe, Nicole Marjon, Miriam D Post, et al.
Gynecologic Oncology|March 27, 2019
Molecular markers in recurrent stage I, grade 1 endometrioid endometrial cancersMarisa R Moroney, Kurtis D Davies, Adam C Wilberger, et al.
Molecular Cancer Therapeutics|October 18, 2012
Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxelDiana M Cittelly, Irina Dimitrova, Erin N Howe, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|November 3, 2023
Prospective Clinical Prognostication of Endometrial Carcinomas Based on Next-Generation Sequencing and Immunohistochemistry-Real-World Implementation and Results at a Tertiary Care CenterKurtis D Davies, Lynelle P Smith, Amy Guimaraes-Young, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|May 26, 2018
The role of the maternal and fetal inflammatory response in retinopathy of prematurityAnne M Lynch, Amber A Berning, Tamara S Thevarajah, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Clinical Epigenetics|November 29, 2019
Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinomaZachary L Watson, Tomomi M Yamamoto, Alexandra McMellen, et al.
American Journal of Obstetrics and Gynecology|February 29, 2024
Placental differences between severe fetal growth restriction and hypertensive disorders of pregnancy requiring early preterm delivery: morphometric analysis of the villous tree supported by artificial intelligenceAnna Jacobs, Saif I Al-Juboori, Evgenia Dobrinskikh, et al.
Oncogenesis|November 28, 2018
CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancerLindsay J Wheeler, Zachary L Watson, Lubna Qamar, et al.
Comparative Medicine|November 12, 2013
Assessing the pulsatility of luteinizing hormone in female vervet monkeys (Chlorocebus aethiops sabaeus)Sahar M Stephens, Francis K Y Pau, Tamer M Yalcinkaya, et al.
Breast Cancer Research and Treatment|December 19, 2012
Estrogen switches pure mucinous breast cancer to invasive lobular carcinoma with mucinous featuresPurevsuren Jambal, Melanie M Badtke, J Chuck Harrell, et al.
Gynecologic Oncology|May 25, 2025
The evolving role of HER2 in gynecologic oncology and clinical trial design: A gynecologic pathologist's perspectiveEseohi Ehimiaghe, Nicole Marjon, Miriam D Post, et al.
Gynecologic Oncology|March 27, 2019
Molecular markers in recurrent stage I, grade 1 endometrioid endometrial cancersMarisa R Moroney, Kurtis D Davies, Adam C Wilberger, et al.
Molecular Cancer Therapeutics|October 18, 2012
Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxelDiana M Cittelly, Irina Dimitrova, Erin N Howe, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|November 3, 2023
Prospective Clinical Prognostication of Endometrial Carcinomas Based on Next-Generation Sequencing and Immunohistochemistry-Real-World Implementation and Results at a Tertiary Care CenterKurtis D Davies, Lynelle P Smith, Amy Guimaraes-Young, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|May 26, 2018
The role of the maternal and fetal inflammatory response in retinopathy of prematurityAnne M Lynch, Amber A Berning, Tamara S Thevarajah, et al.
Pageof 8